Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)
Clinical trial NCT03455439 · COMPLETED
Trial details
- NCT number
- NCT03455439
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-16
- Primary completion
- 2021-07-17
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.